Deciphera Pharmaceuticals, a clinical stage biotechnology company focused on improved kinase inhibitor treatments targeting the tumor microenvironment, today announced the appointment of Oliver Rosen, M.D., as Chief Medical Officer. Dr. Rosen will be responsible for leading the company’s clinical development strategy and clinical operations which includes a pipeline of cancer therapeutics targeting kinases that play an important role in tumor communication with the surrounding tissue. Prior to joining Deciphera, Dr. Rosen held clinical positions in the oncology field at premier biopharmaceutical companies, including Millennium, Genentech, Amgen, Hoffman La Roche and Merck KGaA.
Help employers find you! Check out all the jobs and post your resume.
